This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
L. J. Abu-Raddad , P. Patnaik and J. G. Kublin (2006). Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314, 1603–1606.
R. M. Anderson and R. M. May (1991). Infectious Diseases of Humans: Dynamics and Control, Oxford University Press, UK.
J. B. Andre and T. Day (2005). The effect of disease life history on the evolutionary emergence of novel pathogens. Proceedings of the Royal Society B-Biological Sciences 272, 1949–1956.
R. Antia , R. R. Regoes , J. C. Koella and C. T. Bergstrom (2003). The role of evolution in the emergence of infectious diseases. Nature 426, 658–661.
N. Becker and I. Marschner (1990). The effect of heterogeneity on the spread of disease. In Stochastic Processes in Epidemic Theory, Vol. 86 (eds. P. Picard , J. P. Gabriel and C. Lefevre ), pp. 90–103. Springer-Verlag, New York.
C. Chicharro and J. Alvar (2003). Lower trypanosomatids in HIV/AIDS patients. Annals of Tropical Medicine and Parasitology 97, 75–78.
C. Chicharro , M. I. Jimenez and J. Alvar (2003). Iso-enzymatic variability of Leishmania infantum in Spain. Annals of Tropical Medicine and Parasitology 97, 57–64.
E. L. Corbett , R. W. Steketee , F. O. ter Kuile , A. S. Latif , A. Kamali and R. J. Hayes (2002). HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 359, 2177–2187.
S. L. Croft , S. Sundar and A. H. Fairlamb (2006). Drug resistance in leishmaniasis. Clinical Microbiology Reviews 19, 111–126.
P. C. Cross , J. O. Lloyd-Smith , P. L. F. Johnson and W. M. Getz (2005). Duelling timescales of host movement and disease recovery determine invasion of disease in structured populations. Ecology Letters 8, 587–595.
S. J. Davies , J. L. Grogan , R. B. Blank , K. C. Lim , R. M. Locksley and J. H. McKerrow (2001). Modulation of blood fluke development in the liver by hepatic CD4(+) lymphocytes. Science 294, 1358–1361.
P. Desjeux and J. Alvar (2003). Leishmania/HIV co-infections: epidemiology in Europe. Annals of Tropical Medicine and Parasitology 97, 3–15.
M. J. Doenhoff , O. Hassounah , H. Murare , J. Bain and S. Lucas (1986). The schistosome egg granuloma – immunopathology in the cause of host protection or parasite survival. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 503–514.
A. L. Graham , I. M. Cattadori , J. O. Lloyd-Smith , M. J. Ferrari and O. N. Bjornstad (2007). Transmission consequences of coinfection: cytokines writ large Trends in Parasitology 23, 284–291.
M. Gramiccia (2003). The identification and variability of the parasites causing leishmaniasis in HIV-positive patients in Italy. Annals of Tropical Medicine and Parasitology 97, 65–73.
S. Gupta , J. Swinton and R. M. Anderson (1994). Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proceedings of the Royal Society of London Series B-Biological Sciences 256, 231–238.
G. Harms and H. Feldmeier (2005). The impact of HIV infection on tropical diseases. Infectious Disease Clinics of North America 19, 121–135.
T. E. Harris (1963). The Theory of Branching Processes, Springer, Berlin.
M. Kaare , K. Picozzi , T. Mlengeya , E. Fèvre , L. Mellau , M. Mtambo , S. Cleaveland and S. Welburn (2007). Sleeping sickness – A re-emerging disease in the Serengeti Travel Medicine and Infectious Disease 5, 117–124.
S. N. Kibona , L. Matemba , J. S. Kaboya and G. W. Lubega (2006). Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania. Tropical Medicine and International Health 11, 144–155.
E. L. Korenromp , B. G. Williams , S. J. de Vlas , E. Gouws , C. F. Gilks , P. D. Ghys and B. L. Nahlen (2005). Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerging Infectious Diseases 11, 1410–1419.
F. Laguna (2003). Treatment of leishmaniasis in HIV-positive patients. Annals of Tropical Medicine and Parasitology 97, 135–142.
D. Legros , S. Evans , F. Maiso , J. C. K. Enyaru and D. Mbulamberi (1999). Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 439–442.
J. O. Lloyd-Smith , S. J. Schreiber , P. E. Kopp and W. M. Getz (2005). Superspreading and the effect of individual variation on disease emergence. Nature 438, 355–359.
A. Mathis , R. Weber and P. Deplazes (2005). Zoonotic potential of the microsporidia. Clinical Microbiology Reviews 18, 423–445.
E. Matovu , T. Seebeck , J. C. K. Enyaru and R. Kaminsky (2001). Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes and Infection 3, 763–770.
J. Mermin , J. Lule , J. P. Ekwaru , R. Downing , P. Hughes , R. Bunnell , S. Malamba , R. Ransom , F. Kaharuza , A. Coutinho , A. Kigozi and R. Quick (2005). Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS 19, 1035–1042.
R. Molina , L. Gradoni and J. Alvar (2003). HIV and the transmission of Leishmania. Annals of Tropical Medicine and Parasitology 97, 29–45.
N. J. Pieniazek , F. J. Bornay-Llinares , S. B. Slemenda , A. J. da Silva , I. N. S. Moura , M. J. Arrowood , O. Ditrich and D. G. Addiss (1999). New Cryptosporidium genotypes in HIV-infected persons. Emerging Infectious Diseases 5, 444–449.
T. C. Porco , P. M. Small and S. M. Blower (2001). Amplification dynamics: Predicting the effect of HIV on tuberculosis outbreaks. Journal of Acquired Immune Deficiency Syndromes 28, 437–444.
F. Pratlong , J. Dereure , M. Deniau , P. Marty , F. Faraut-Gambarelli and J. P. Dedet (2003). Enzymatic polymorphism during Leishmania/HIV co-infection: a study of 381 Leishmania strains received between 1986 and 2000 at the international cryobank in Montpellier, France. Annals of Tropical Medicine and Parasitology 97, 47–56.
N. S. Redhu , A. Dey , V. Balooni and S. Singh (2006). Leishmania-HIV co-infection: an emerging problem in India. AIDS 20, 1213–1214.
J. P. Van Geertruyden , M. Mulenga , L. Mwananyanda , V. Chalwe , F. Moerman , R. Chilengi , W. Kasongo , C. Van Overmeir , J. C. Dujardin , R. Colebunders , L. Kestens and U. D'Alessandro (2006). HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. Journal of Infectious Diseases 194, 917–925.
M. E. Viney , M. Brown , N. E. Omoding , J. W. Bailey , M. P. Gardner , E. Roberts , D. Morgan , A. M. Elliott and J. A. G. Whitworth (2004). Why does HIV infection not lead to disseminated strongyloidiasis Journal of Infectious Diseases 190, 2175–2180.
N. J. White (2004). Antimalarial drug resistance. Journal of Clinical Investigation 113, 1084–1092.
J. Whitworth , D. Morgen , M. Quigley , A. Smith , S. Mayanja , H. Eotu , N. Omoding , M. Okongo , S. Malamba and A. Ojwiya (2000). Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356, 1051–1056.
B. G. Williams and C. Dye (2003). Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 301, 1535–1537.
B. G. Williams , E. L. Korenromp , E. Gouws , G. P. Schmid , B. Auvert and C. Dye (2006). HIV infection, Antiretroviral therapy, and CD4(+) cell count distributions in African populations. Journal of Infectious Diseases 194, 1450–1458.
M. E. J. Woolhouse , C. Dye , J. F. Etard , T. Smith , J. D. Charlwood , G. P. Garnett , P. Hagan , J. L. K. Hii , P. D. Ndhlovu , R. J. Quinnell , C. H. Watts , S. K. Chandiwana and R. M. Anderson (1997). Heteropeneities in the transmission of infectious agents Implications for the design of control programs. Proceedings of the National Academy of Sciences, USA 94, 338–342.
M. E. J. Woolhouse , D. T. Haydon and R. Antia (2005). Emerging pathogens: the epidemiology and evolution of species jumps. Trends in Ecology and Evolution 20, 238–244.
A. Yates , R. Antia and R. R. Regoes (2006). How do pathogen evolution and host heterogeneity interact in disease emergence Proceedings of the Royal Society B-Biological Sciences 273, 3075–3083.